Central retinal vein oclusion

PURPOSE: We detail a unique case of a healthy 33-year-old suspected COVID-19 patient who presented with unilateral Central Retinal Vein Occlusion, possibly as a complication of COVID-19. OBSERVATIONS: A 33-year-old healthy male was referred to the emergency department due to blurred vision in his left eye for the past month, accompanied by flashes of light without any accompanying neurological symptoms. The patient reported a three-week period of fatigue, dry cough, and shortness of breath ended about 2 weeks prior to the ocular symptoms...

BACKGROUND: Macular edema is one of the most common causes of visual loss in patients with retinal vein oclusions. Intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factors are modalities of treatment for macular edema secondary to branch retinal vein occlusion (BRVO). OBJECTIVE: To present the results of intravitreal triamcinolone acetonide therapy in patients with macular edema secondary to BRVO. SETTING: A retrospective clinical interventional study included 32 patients with macular edema secondary to BRVO...